(Q35157953)

English

Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs). (English)

1 reference

Europe PubMed Central

6 August 2017

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

author name string

Tsukasa Nakamura

1

1 reference

Europe PubMed Central

6 August 2017

Eiichi Sato

2

1 reference

Europe PubMed Central

6 August 2017

Nobuharu Fujiwara

3

1 reference

Europe PubMed Central

6 August 2017

Yasuhiro Kawagoe

4

1 reference

Europe PubMed Central

6 August 2017

Masayoshi Takeuchi

5

1 reference

Europe PubMed Central

6 August 2017

Sayaka Maeda

6

1 reference

Europe PubMed Central

6 August 2017

Sho-ichi Yamagishi

7

1 reference

Europe PubMed Central

6 August 2017

publication date

1 September 2010

1 reference

Europe PubMed Central

6 August 2017

Oxidative medicine and cellular longevity

1 reference

Europe PubMed Central

6 August 2017

3

1 reference

Europe PubMed Central

6 August 2017

5

1 reference

Europe PubMed Central

6 August 2017

304-307

1 reference

Europe PubMed Central

6 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Advanced glycation end products, oxidative stress and diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Oxidative stress as a mediator of cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

HMG CoA reductase inhibitors and renoprotection: the weight of the evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Atorvastatin and diabetic vascular complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Pathophysiology of proteinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

The role of proteinuria in the progression of chronic renal failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Advanced protein glycosylation in diabetes and aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

13 July 2018

Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

27 September 2018

Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

27 September 2018

The acute effect of atorvastatin on proteinuria in patients with chronic glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

27 September 2018

Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154036

27 September 2018

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of statins on renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal expression of constitutive NOS and DDAH: separate effects of salt intake and angiotensin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4161/OXIM.3.5.13069

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35157953&oldid=1990170336"